After buying out Flexion for $450M, Pacira quietly lays off 110 of its employees
After being acquired by Pacira Biosciences in a $450 million deal, it looks like Flexion Therapeutics quietly brought out the axe.
While details remain few and short, here’s what we know: The company reported a layoff to Massachusetts as part of the state’s Worker Adjustment and Retaining Act (WARN) — something companies are obliged to do when there are impending layoffs — and listed in last week’s report. According to the report, 110 employees had been shown the door. The company listed the layoff date as Jan. 18 with no corporate announcement.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.